Lumida
/ACNB
⌘K
ACNB Corp

ACNB Corp

ACNB
$65.19USD+0.26%+0.17 today

MARKET CAP

663.0M

P/E (TTM)

18.4x

FWD P/E

DAY RANGE

$65 – $66

52W RANGE

$43
$68

AI Summary

Stalk
StalkMedium

ACNB remains in a robust Stage 2 advance with bullish medium and long-term biases. However, price is extended above rising EMAs and in extreme overbought territory, suggesting deferred engagement. Optimal entries on pullbacks into the 9EMA–21EMA confluence or prior resistance-turned-support area. A decisive break below the EMAs would invalidate the bullish thesis.

  • Q2 revenue $52.5M (+4.4% YoY); net income $15.2M (+31%), EPS $1.49 vs $1.38 est.
  • Opened Berks County loan office to drive commercial lending growth.
  • Director sold 1,500 shares (~$96K), undermining insider confidence.
Full analysis →

Buying

5

institutions

Selling

2

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY705.13 K41.87 M+82.55 K+40.5%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL42.93 K2.55 M+-2.55 K+17.1%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY37.94 K2.25 M+28.66 K+406.9%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

BUY31.25 K1.86 M+4.95 K+47.4%0.00%
MM

Millennium Management LLC

Q2 2026

BUY24.51 K1.46 M+4.39 K+51.1%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL24.36 K1.45 M+-200.00+23.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY5.04 K301.81 K+273.00+33.2%0.00%